Momentum

Relative Strength (%)
1m-37.14%
3m-21.17%
6m-30.4%
1yr+10.63%
Volume Change (%)
10d/3m+21.61%
Price vs... (%)
52w High-54.55%
50d MA-29.35%
200d MA-22.04%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capitaln/a
Return on Equityn/a
Operating Marginn/a

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS  /

Blurred out image of SOHM EPS forecast chart

Profile Summary

SOHM, Inc. is a pharmaceutical manufacturer that produces and markets generic drugs for various treatment categories. The Company is focused on developing, manufacturing and distributing generic, branded generic, private label pharmaceuticals, cosmeceuticals and nutraceutical products. The Company has expertise in various drug delivery technologies, including solid dosage from, oral-controlled and sustained releases semi-solid, liquid, oral trans mucosal, transdermal, gel, injectable, and other drug delivery technologies, and the application of these technologies to drug forms. Its product list includes analgesics, antibiotics, anti-cold, anti-flammatory, beta-lactum antibodies, capsules, drops, injections, suspension, syrup, tablets, vitamins and tonics. The Company markets and sells its generic drugs globally and focuses primarily on markets in Africa, Latin America, Southeast Asia and the European Union.

Directors

    Last Annual
    Last Interim
    Incorporated
    July 6th, 2005
    Public Since
    October 11th, 2006
    Sector
    Pharmaceuticals
    Industry
    Healthcare
    Exchange
    us flag iconPink Sheets on Nasdaq
    Shares in Issue
    1,600,576,407

    SHMN Share Price Performance

    Similar to SHMN

    Picture of Acusphere logo

    Acusphere

    us flag iconPink Sheets on Nasdaq

    Picture of Adorbs logo

    Adorbs

    us flag iconPink Sheets on Nasdaq

    Picture of Agentix logo

    Agentix

    us flag iconPink Sheets on Nasdaq

    Picture of Agrios Global Holdings logo

    Agrios Global Holdings

    us flag iconPink Sheets on Nasdaq

    Picture of Aida Pharmaceuticals logo

    Aida Pharmaceuticals

    us flag iconPink Sheets on Nasdaq

    FAQ